ANI Pharmaceuticals

ANIP

Insider trades and stock quote 2024-2026

All insider trades at ANI Pharmaceuticals

Subscribe RSS
Date Type Insider Position Ø-Price Volume
7/29/2026 Sell Carey, Stephen P. SVP & CFO $81.4 $231,876
7/13/2026 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $81.8 $40,920
7/2/2026 Sell Carey, Stephen P. SVP & CFO $86.0 $284,918
6/29/2026 Sell Carey, Stephen P. SVP & CFO $84.1 $239,742
6/12/2026 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $82.0 $41,015
6/8/2026 Sell Haughey, Thomas Director $80.9 $161,760
6/5/2026 Sell Carey, Stephen P. SVP & CFO $80.0 $264,960
5/13/2026 Sell Walsh, Patrick D. Director $80.6 $806,300
5/13/2026 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $78.2 $39,080
5/12/2026 Sell Rowland, Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS $79.2 $36,357
5/12/2026 Sell Gutwerg, Ori SVP, GENERICS $79.5 $220,374
5/11/2026 Sell Walsh, Patrick D. Director $80.8 $320,820
5/11/2026 Sell Lalwani, Nikhil PRESIDENT & CEO $77.6 $4,266,350
4/13/2026 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $78.0 $38,975
3/13/2026 Sell Mutz, Christopher HEAD OF RARE DISEASE $71.6 $226,526
3/13/2026 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $72.6 $36,310
3/11/2026 Sell Rowland, Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS $74.9 $357,471
3/9/2026 Sell Mutz, Christopher HEAD OF RARE DISEASE $74.2 $267,196
3/9/2026 Sell Davis, Krista SVP, CHIEF HR OFFICER $74.1 $377,099
3/6/2026 Sell Mutz, Christopher HEAD OF RARE DISEASE $74.2 $157,421
3/6/2026 Sell Davis, Krista SVP, CHIEF HR OFFICER $75.0 $111,375
3/5/2026 Sell Carey, Stephen P. SVP & CFO $75.5 $552,031
3/3/2026 Sell Walsh, Patrick D. Director $74.2 $445,380
3/3/2026 Sell Gutwerg, Ori SVP, GENERICS $76.5 $157,590
3/2/2026 Sell Mutz, Christopher HEAD OF RARE DISEASE $74.0 $30,858
2/20/2026 Sell Mutz, Christopher HEAD OF RARE DISEASE $78.0 $415,300
2/20/2026 Sell Davis, Krista SVP, CHIEF HR OFFICER $78.0 $134,923
2/19/2026 Sell Davis, Krista SVP, CHIEF HR OFFICER $77.5 $161,573
2/13/2026 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $76.8 $38,400
2/12/2026 Sell Mutz, Christopher HEAD OF RARE DISEASE $76.6 $538,300
1/13/2026 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $84.3 $42,165
12/18/2025 Sell Davis, Krista SVP, CHIEF HR OFFICER $82.4 $133,653
12/12/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $82.3 $32,928
12/5/2025 Sell Tannenbaum, Renee P. Director $81.2 $146,070
11/13/2025 Sell Walsh, Patrick D. Director $86.9 $750,904
11/13/2025 Sell Gassert, Chad SVP - CORP. DEV. & STRATEGY $88.0 $8,272
11/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $87.3 $34,908
11/12/2025 Sell Gassert, Chad SVP - CORP. DEV. & STRATEGY $89.1 $1,304,163
10/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $90.1 $36,036
9/19/2025 Sell Davis, Krista SVP, CHIEF HR OFFICER $98.0 $98,040
9/12/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $98.4 $39,368
9/3/2025 Sell Pera, Antonio R. Director $94.9 $692,302
8/25/2025 Sell Leonard, Matthew J. Director $90.6 $229,087
8/22/2025 Sell Davis, Krista SVP, CHIEF HR OFFICER $91.1 $160,609
8/21/2025 Sell Shanmugam, Muthusamy HEAD OF R&D, COO-NOVITIUM OPS $90.4 $4,792,235
8/20/2025 Sell Pera, Antonio R. Director $89.7 $486,426
8/20/2025 Sell Shanmugam, Muthusamy HEAD OF R&D, COO-NOVITIUM OPS $90.3 $4,243,773
8/18/2025 Sell Leonard, Matthew J. Director $88.2 $611,635
8/18/2025 Sell Thoma, Jeanne Director $89.3 $1,920,369
8/15/2025 Sell Walsh, Patrick D. Director $89.0 $801,450
8/15/2025 Sell Shanmugam, Muthusamy HEAD OF R&D, COO-NOVITIUM OPS $87.2 $4,618,079
8/15/2025 Sell Gassert, Chad SVP - CORP. DEV. & STRATEGY $87.0 $1,739,400
8/14/2025 Sell Shanmugam, Muthusamy HEAD OF R&D, COO-NOVITIUM OPS $89.5 $4,206,455
8/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $88.9 $35,548
8/12/2025 Sell Haughey, Thomas Director $85.9 $1,661,972
8/12/2025 Sell Rowland, Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS $85.7 $426,407
8/12/2025 Sell Carey, Stephen P. SVP & CFO $86.1 $4,303,500
8/12/2025 Sell Lalwani, Nikhil PRESIDENT & CEO $85.9 $4,894,573
8/12/2025 Sell Gutwerg, Ori SVP, GENERICS $86.5 $508,191
7/14/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $64.9 $25,952
6/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $61.4 $24,548
5/15/2025 Sell Gutwerg, Ori SVP, GENERICS $60.1 $52,922
5/14/2025 Sell Mutz, Christopher HEAD OF RARE DISEASE $60.4 $241,800
5/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $62.2 $24,880
5/9/2025 Sell Shanmugam, Muthusamy HEAD OF R&D, COO-NOVITIUM OPS $76.8 $53,781
4/14/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $69.0 $27,584
3/19/2025 Sell Davis, Krista SVP, CHIEF HR OFFICER $65.0 $121,290
3/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $63.3 $25,332
3/7/2025 Sell Davis, Krista SVP, CHIEF HR OFFICER $60.9 $60,860
3/5/2025 Sell Gutwerg, Ori SVP, GENERICS $60.0 $323,049
2/21/2025 Sell Davis, Krista SVP, CHIEF HR OFFICER $60.2 $60,200
2/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $59.5 $23,816
1/13/2025 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $53.9 $21,568
12/17/2024 Sell Carey, Stephen P. SVP & CFO $55.8 $418,425
12/13/2024 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $56.2 $14,060
12/11/2024 Sell Davis, Krista SVP, CHIEF HR OFFICER $60.0 $60,000
11/26/2024 Sell Lalwani, Nikhil PRESIDENT & CEO $58.1 $1,941,442
11/15/2024 Sell Mutz, Christopher HEAD OF RARE DISEASE $57.7 $375,050
11/13/2024 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $61.4 $15,340
10/14/2024 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $57.2 $14,298
9/13/2024 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $56.8 $14,205
8/13/2024 Sell Cook, Meredith SR. VP, GENERAL COUNSEL & SEC. $59.6 $14,905
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)